TLX
Telix Pharmaceuticals Ltd
$11.87
+0.03 (+0.25%)
At close · Jul 2
Market Cap
$4.02B
Shares
338,777,049
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-02 | 2026-07-01 | |
| 6-K | 2026-05-21 | 2025-05-20 | |
| 6-K | 2026-04-23 | 2026-04-22 | |
| 6-K | 2026-04-21 | 2026-04-20 | |
| 6-K | 2026-04-20 | 2026-04-19 | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-13 | 2026-04-12 | |
| 6-K | 2026-04-10 | 2026-04-09 | |
| 6-K | 2026-04-09 | — | |
| 6-K | 2026-04-07 | 2026-03-31 | |
| 6-K | 2026-04-02 | 2026-04-01 | |
| 6-K | 2026-03-16 | 2026-03-15 | |
| 6-K | 2026-03-10 | 2026-03-09 | |
| 20-F | 2026-02-20 | 2025-12-31 | |
| 6-K | 2026-02-19 | 2026-02-17 | |
| 6-K | 2026-02-18 | 2026-02-17 | |
| 6-K | 2026-02-03 | 2026-02-02 | |
| 6-K | 2026-01-20 | 2026-01-19 | |
| 6-K | 2026-01-12 | — | |
| 6-K | 2025-12-22 | 2025-12-21 | |
| 6-K | 2025-12-17 | — | |
| 6-K | 2025-12-08 | 2025-12-07 | |
| 6-K | 2025-10-14 | — | |
| 6-K | 2025-09-23 | 2025-09-22 | |
| 6-K | 2025-09-09 | 2025-09-08 | |
| 6-K | 2025-08-28 | 2025-08-04 | |
| 6-K | 2025-08-21 | 2025-08-20 | |
| 6-K | 2025-07-22 | — | |
| 6-K | 2025-07-09 | 2025-07-08 | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-05-21 | 2025-05-20 | |
| 6-K | 2025-04-29 | 2025-04-27 | |
| 6-K | 2025-04-22 | — | |
| 6-K | 2025-04-17 | 2025-04-15 | |
| 6-K | 2025-04-17 | 2025-04-16 | |
| 6-K | 2025-04-08 | 2025-04-06 | |
| 6-K | 2025-04-04 | 2025-04-03 | |
| 6-K | 2025-03-21 | 2025-03-20 | |
| 6-K | 2025-03-18 | 2025-03-17 | |
| 6-K | 2025-03-12 | 2025-03-11 | |
| 6-K | 2025-02-27 | 2025-02-25 | |
| 6-K | 2025-02-26 | 2025-02-25 | |
| 6-K | 2025-02-25 | — | |
| 20-F | 2025-02-24 | 2024-12-31 | |
| 6-K | 2025-02-24 | — | |
| 6-K | 2025-02-21 | 2025-02-20 | |
| 6-K | 2025-02-13 | 2025-02-12 | |
| 6-K | 2025-01-31 | 2025-01-30 | |
| 6-K | 2025-01-27 | — |
Showing 1–50 of 56 filings